[
Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal
[og_img]
https://www.investing.com/news/press-releases/clinical-research-results-for-kelunbiotechs-trop2-adc-sacituzumab-tirumotecan-sact-published-in-nature-medicine-a-top-international-medical-journal-93CH-3982404
Investing.com
Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal
Related articles
